HOME ·

MABWELL-B

MABWELL-B (02493.HK): Phase II Data for 9MW2821 in TNBC to Be Presented at ESMO 2026; ORR 30.0%
Tags：
NewTimeSpaceMABWELL-B02493.HK
2026-10-19
HK Recently Listed Stocks Watch | MABWELL-B (02493.HK) 1H Revenue up 209.04% YoY, 15.0206 Million Cornerstone Lock-up Shares to Be Unlocked on October 28
Tags：
MABWELL-B02493.HKRecently Listed Stocks
2026-09-23
Mabwell-B(02493.HK): IND Application of 9MW5211 Injection for Type 1 Diabetes Mellitus Accepted by NMPA
Tags：
MABWELL-B02493.HKClinical Trial
2026-07-07
Mabwell-B (02493.HK)： 6MW5311 Clinical Trial Application Approved by NMPA
Tags：
MABWELL-B02493.HKTrial Application
2026-06-23
Mabwell-B (02493.HK): 6MW5311 Injection Receives FDA Clinical Trial Approval as World’s First LILRB4/CD3-Targeted TCE Innovative Drug
Tags：
MABWELL-B02493.HKClinicalTrialApproval
2026-06-12